PMV Pharmaceuticals
PMVP
PMVP
73 hedge funds and large institutions have $2.33B invested in PMV Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 14 closing their positions.
Holders
73
Holders Change
+22
Holders Change %
+43.14%
% of All Funds
1.3%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
36
Increased
19
Reduced
11
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EC
1
Euclidean Capital
New York
|
$257M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$71.3M |
| 3 |
3
BlackRock
New York
|
$82.7M |
| 4 |
4
Alkeon Capital Management
New York
|
$69.3M |
| 5 |
ACA
5
Avoro Capital Advisors
New York
|
$131M |
